Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumors, Neuroendocrine”

4,688 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,688 results

Testing effectiveness (Phase 2)Looking for participantsNCT04349436
What this trial is testing

A Phase 1B/2 Study of RP1 in Solid Organ Transplant Patients With Advanced Cutaneous Malignancies

Who this might be right for
Cutaneous Squamous Cell CarcinomaMerkel Cell CarcinomaBasal Cell Carcinoma+1 more
Replimune Inc. 65
Not applicableWithdrawnNCT00657332
What this trial is testing

Clinical and Pathologic Studies in Neuroendocrine Tumors

Who this might be right for
Carcinoid TumorNeuroendocrine Tumors
Stanford University
Testing effectiveness (Phase 2)Ended earlyNCT01533948
What this trial is testing

Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Extraocular Extension MelanomaMetastatic Intraocular MelanomaRecurrent Intraocular Melanoma+9 more
Roswell Park Cancer Institute 25
Testing effectiveness (Phase 2)Ended earlyNCT03095248
What this trial is testing

Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors

Who this might be right for
Neurofibromatosis 2Vestibular SchwannomaMeningioma+2 more
Children's Hospital Medical Center, Cincinnati 10
Testing effectiveness (Phase 2)Study completedNCT02923934
What this trial is testing

A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers

Who this might be right for
Gastrointestinal CancerNeuroendocrine TumoursMalignant Female Reproductive System Neoplasm
Olivia Newton-John Cancer Research Institute 120
Not applicableStudy completedNCT04123678
What this trial is testing

DERM Health Economics Study

Who this might be right for
MelanomaNon-melanoma Skin Cancer
Skin Analytics Limited 700
Testing effectiveness (Phase 2)Study completedNCT01961115
What this trial is testing

Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma

Who this might be right for
Mucosal MelanomaRecurrent MelanomaRecurrent Uveal Melanoma+8 more
Fred Hutchinson Cancer Center 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT04291885
What this trial is testing

Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma

Who this might be right for
Merkel Cell CarcinomaMerkel Cell Carcinoma, Stage IMerkel Cell Carcinoma, Stage II+3 more
Melanoma and Skin Cancer Trials Limited 122
Not applicableStudy completedNCT04576416
What this trial is testing

Artificial Intelligence Augmented Training in Skin Cancer Diagnostics for General Practitioners

Who this might be right for
MelanomaSkin Cancer
Herlev Hospital 115
Testing effectiveness (Phase 2)Study completedNCT02113800
What this trial is testing

Safety and Tolerability of Everolimus as Second-line Treatment in Poorly Differentiated Neuroendocrine Carcinoma / Neuroendocrine Carcinoma G3 (WHO 2010) and Neuroendocrine Tumor G3 - an Investigator Initiated Phase II Study

Who this might be right for
Poorly Differentiated Malignant Neuroendocrine CarcinomaNeuroendocrine Carcinoma, Grade 3Neuroendocrine Carcinoma, Grade 1 [Well-differentiated Neuroendocrine Carcinoma] That Switched to G3+2 more
AIO-Studien-gGmbH
Not applicableStudy completedNCT06694571
What this trial is testing

Sun Protection and Tanning Awareness in Rural Schools

Who this might be right for
MelanomaAdolescents
University of Utah 38
Early research (Phase 1)Looking for participantsNCT06479811
What this trial is testing

[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

Who this might be right for
Head and Neck TumorsKidney CancersSmall Cell Lung Cancers+3 more
National Cancer Institute (NCI) 120
Early research (Phase 1)Active Not RecruitingNCT05614102
What this trial is testing

A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bayer 284
Early research (Phase 1)Study completedNCT04702737
What this trial is testing

AMG 757 in Participants With Neuroendocrine Prostate Cancer

Who this might be right for
Neuroendocrine Prostate Cancer
Amgen 41
Large-scale testing (Phase 3)UnknownNCT01088737
What this trial is testing

Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna

Who this might be right for
Lentigo Maligna
Medical University of Graz 60
Testing effectiveness (Phase 2)Study completedNCT01009177
What this trial is testing

Effect of Bosentan in Patients With Metastatic Melanoma Treated With Dacarbazine (DTIC)

Who this might be right for
Melanoma
Actelion 80
Large-scale testing (Phase 3)Ended earlyNCT00092287
What this trial is testing

Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome

Who this might be right for
Malignant Carcinoid Syndrome
Ipsen 4
Testing effectiveness (Phase 2)Study completedNCT00204516
What this trial is testing

Vaccination With Tumor mRNA in Metastatic Melanoma - Fixed Combination Versus Individual Selection of Targeted Antigens

Who this might be right for
Malignant Melanoma
University Hospital Tuebingen 31
Testing effectiveness (Phase 2)Study completedNCT01207687
What this trial is testing

Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)

Who this might be right for
Vestibular SchwannomaNeurofibromatosis Type 2
National Cancer Institute (NCI) 14
Not applicableNo Longer AvailableNCT04489433
What this trial is testing

Compassionate Use Program to Access Trametinib and Dabrafenib for Patients With BRAF Mutation-positive Metastatic Melanoma

Who this might be right for
Melanoma
Novartis Pharmaceuticals
Load More Results
40